# Swedish Orphan Biovitrum AB (Publ) – FDA Inspection, May 4, 2018

Source: https://www.keypedia.com/records/fda_inspections/swedish-orphan-biovitrum-ab-publ/fedd8529-51b4-48a4-a3ce-9099fcb8a7d3
Source feed: FDA_Inspections

> FDA inspection 1050664 of Swedish Orphan Biovitrum AB (Publ), May 04, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050664
- Company Name: Swedish Orphan Biovitrum AB (Publ)
- Inspection Date: 2018-05-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1105180 - 2019-08-29
- FDA Inspection 965894 - 2016-03-22
- FDA Inspection 886772 - 2014-05-01
- FDA Inspection 822730 - 2013-02-22
- FDA Inspection 725457 - 2011-01-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/stephen-d-brown/01ff1439-f6d7-4501-a104-573dae30d306)

Company: https://www.keypedia.com/companies/swedish-orphan-biovitrum-ab-publ/ce015a15-5a97-47dd-9e01-2bd5eb4b40f7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c